TEGLUTIK (riluzole): Reviews and patient testimonials
Back to the list of medications
Medication indications
TEGLUTIK 5 mg/ml oral suspension
TEGLUTIK is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS).
Clinical trials have demonstrated that riluzole extends survival for patients with ALS. Survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free.
There is no evidence that TEGLUTIK exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms. TEGLUTIK has not been shown to be effective in the late stages of ALS.
Safety and efficacy of TEGLUTIK has only been studied in ALS. Therefore, TEGLUTIK should not be used in patients with any other form of motor neurone disease.
Route of administration: Oral
Molecule: riluzole
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.